Trends in Prevalence of HIV-1 Drug Resistance in Thailand 2009-2010
- 13 September 2013
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 27 (5), 346-353
- https://doi.org/10.1002/jcla.21609
Abstract
Background Treatment failure of antiretroviral therapy in HIV‐1 infection is increasing due to development of viral resistance. Trends of resistance‐associated mutation lead to the ineffective treatment in HIV‐infected individuals. Methods Extracted viral RNA from HIV‐infected subjects in 2009 to 2010 was performed. The genotypic resistance testing was investigated for HIV‐1 drug resistance in RT and PR genes. Frequencies of mutation were compared by a Fischer's exact test. Results Three hundred and sixty‐nine samples (147 in 2009 and 222 in 2010) were genotyped. At least one mutation was found in 90.8% (335/369) in PR gene and 87.0% (321/369) in RT gene. Three sequences in PR gene, M36I, H69K, and L90M, were decreased significantly in 2010 when compared to 2009. Mutations associated with resistance to nucleoside analogue reverse transcriptase inhibitors (NRTI's) were found in 61.0% and 64.2% in nonnucleoside analogue reverse transcriptase inhibitors (NNRTI's). A total of 49.6% was found in combined NRTI and NNRTI. In 2010, M41L was increased significantly from 7.5% to 14.9%. However, there was a decrease in the frequency of the mutations at position 67, 70, and 184 between 2009 and 2010. Conclusions In 2010, three mutations in PR gene, M36I, H69K, and L90M, were decreased significantly. However, only one mutation in RT gene, M41L was significantly increased.Keywords
This publication has 92 references indexed in Scilit:
- Transmitted HIV Resistance to First-Line Antiretroviral Therapy in Lima, PeruAIDS Research and Human Retroviruses, 2012
- Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern GreeceJournal of Antimicrobial Chemotherapy, 2011
- Prevalence of Genotypic Resistance to Antiretroviral Drugs in Treatment-Naive Youths Infected with Diverse HIV Type 1 Subtypes and Recombinant Forms in Dar es Salaam, TanzaniaAIDS Research and Human Retroviruses, 2011
- Transmitted HIV Type 1 Drug Resistance Among Individuals with Recent HIV Infection in East and Southern AfricaAIDS Research and Human Retroviruses, 2011
- Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First‐Line Antiretroviral Therapy in South AfricaClinical Infectious Diseases, 2009
- Trends in Multidrug Treatment Failure and Subsequent Mortality among Antiretroviral Therapy–Experienced Patients with HIV Infection in North AmericaClinical Infectious Diseases, 2009
- Analysis of the diversity of the HIV‐1 pol gene and drug resistance associated changes among drug‐naïve patients in Burkina FasoJournal of Medical Virology, 2009
- High Frequency of Antiretroviral Drug Resistance among HIV‐Infected Adults Receiving First‐Line Highly Active Antiretroviral Therapy in N’Djamena, ChadClinical Infectious Diseases, 2009
- Molecular Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 in Yaoundé, Cameroon: Evidence of Major Drug Resistance Mutations in Newly Diagnosed Patients Infected with Subtypes Other than Subtype BJournal of Clinical Microbiology, 2008
- Transmitted Human Immunodeficiency Virus Type 1 Carrying the D67N or K219Q/E Mutation Evolves Rapidly to Zidovudine Resistance In Vitro and Shows a High Replicative Fitness in the Presence of ZidovudineJournal of Virology, 2004